2026 Q1 -tulosraportti
81 päivää sitten
‧1 t 2 min
7,95 DKK/osake
Viimeisin osinko
3,65%Tuotto/v
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 5.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 6.5. | ||
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 5.11.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·21 min sitten · MuokattuHow can many influencer types post so much on social media (before and after pictures) about the use of Lilly's Retatrutide, which is obviously meant to increase awareness of the product before it is FDA approved? It seems they are instructed to call it ""Reta"" - probably because the product is not approved yet! But in the week where we have heard something about Lilly's advertising design, I can't help but wonder if this is okay?? Lilly is not directly the sender of it, but must have some form of responsibility if the people are participating as tests in a phase study. Where else would they get the product from. (Cannot document that it is a Lilly product) https://www.reddit.com/r/BodyHackGuide/s/QFdcpzsFY4
·2 t sitten · MuokattuThe Novo share has risen approximately 1.5 percent under Mike Doustar. The CEO stated about his own role when he took office approximately 1 year ago, among other things: "I believe I have ended up in this position because I execute and outperform my competitors." He likewise said that when people ask about the difference between him and former CEO Lars Fruergaard, they answer: "Mike Doustdar is really fast, commercially oriented, Mike is competitive., Mike is confident." In other words, the confident CEO set a clear and more aggressive course for the pharmaceutical giant when he took over the company. It will be interesting to see if he can follow up on the things he has promised. Regarding the lawsuit against Eli Lilly, it is an expression of, and it is commendable, that Novo Nordisk now speaks up if something is wrong. I believe we will see Novo Nordisk more offensive in the protection of its intellectual property rights and at the same time step up the marketing effort in all markets, but especially in the USA.
·6 t sittenDear all I would like to suggest that we try to keep posts and discussions within a framework of “what is relevant for most”. Arguments for and against etc. perspectives and questions. With wishes for a likewise proper and factual tone By the way. Whether there are many trolls in here or if some know each other from other forums, I cannot discern, but it succeeds in muddying the forum. Unfortunately, it can have the effect that fewer people feel encouraged to contribute to the conversation, and personally, I completely stop orienting myself due to the noise that the thread is characterized by. In that way, the forum loses its function. From here, with great understanding that one is tempted to “retaliate” to the critical counter-posts that come, I hope that we can restore order in the forum and perhaps sometimes sit on our hands when the factual content has disappeared from the conversation 🙌🏻 Happy Sunday from here ☕️Completely agree! I believe that many serious debaters have been scared away. It would be wonderful if we didn't have to hear about buys, sells and what one has eaten and drunk.- ·1 päivä sitten · MuokattuLooking forward to Q2-Q3-Q4 etc. Novo has, in my opinion, fallen too far in price. After some years 2022-2024 with enormous growth and reward of the stock price, growth has now been around 0, which has occurred after the years of enormous growth. The price has subsequently been punished more than reasonably and incorrectly signals a company in crisis (P/E). If growth, on the other hand, had come more gradually, we would probably have had a higher stock price on a smaller earnings report. Novo is priced as if the obesity market has never been there and will not come in the future - something that could not be further from reality. 💊💊That's fine Progression - I decline your inquiries going forward. As long as I comply with the guidelines on Nordnet, I am not accountable for your interpretations. And if I don't comply with the guidelines, you simply use the report function that you know so well - then we completely avoid communicating!
·1 päivä sittenHave the Americans written about this lawsuit? If so, have they highlighted Novo's arguments. It is important if one is to be able to use this in marketing.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q1 -tulosraportti
81 päivää sitten
‧1 t 2 min
7,95 DKK/osake
Viimeisin osinko
3,65%Tuotto/v
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·21 min sitten · MuokattuHow can many influencer types post so much on social media (before and after pictures) about the use of Lilly's Retatrutide, which is obviously meant to increase awareness of the product before it is FDA approved? It seems they are instructed to call it ""Reta"" - probably because the product is not approved yet! But in the week where we have heard something about Lilly's advertising design, I can't help but wonder if this is okay?? Lilly is not directly the sender of it, but must have some form of responsibility if the people are participating as tests in a phase study. Where else would they get the product from. (Cannot document that it is a Lilly product) https://www.reddit.com/r/BodyHackGuide/s/QFdcpzsFY4
- ·2 t sitten · MuokattuThe Novo share has risen approximately 1.5 percent under Mike Doustar. The CEO stated about his own role when he took office approximately 1 year ago, among other things: "I believe I have ended up in this position because I execute and outperform my competitors." He likewise said that when people ask about the difference between him and former CEO Lars Fruergaard, they answer: "Mike Doustdar is really fast, commercially oriented, Mike is competitive., Mike is confident." In other words, the confident CEO set a clear and more aggressive course for the pharmaceutical giant when he took over the company. It will be interesting to see if he can follow up on the things he has promised. Regarding the lawsuit against Eli Lilly, it is an expression of, and it is commendable, that Novo Nordisk now speaks up if something is wrong. I believe we will see Novo Nordisk more offensive in the protection of its intellectual property rights and at the same time step up the marketing effort in all markets, but especially in the USA.
- ·6 t sittenDear all I would like to suggest that we try to keep posts and discussions within a framework of “what is relevant for most”. Arguments for and against etc. perspectives and questions. With wishes for a likewise proper and factual tone By the way. Whether there are many trolls in here or if some know each other from other forums, I cannot discern, but it succeeds in muddying the forum. Unfortunately, it can have the effect that fewer people feel encouraged to contribute to the conversation, and personally, I completely stop orienting myself due to the noise that the thread is characterized by. In that way, the forum loses its function. From here, with great understanding that one is tempted to “retaliate” to the critical counter-posts that come, I hope that we can restore order in the forum and perhaps sometimes sit on our hands when the factual content has disappeared from the conversation 🙌🏻 Happy Sunday from here ☕️Completely agree! I believe that many serious debaters have been scared away. It would be wonderful if we didn't have to hear about buys, sells and what one has eaten and drunk.
- ·1 päivä sitten · MuokattuLooking forward to Q2-Q3-Q4 etc. Novo has, in my opinion, fallen too far in price. After some years 2022-2024 with enormous growth and reward of the stock price, growth has now been around 0, which has occurred after the years of enormous growth. The price has subsequently been punished more than reasonably and incorrectly signals a company in crisis (P/E). If growth, on the other hand, had come more gradually, we would probably have had a higher stock price on a smaller earnings report. Novo is priced as if the obesity market has never been there and will not come in the future - something that could not be further from reality. 💊💊That's fine Progression - I decline your inquiries going forward. As long as I comply with the guidelines on Nordnet, I am not accountable for your interpretations. And if I don't comply with the guidelines, you simply use the report function that you know so well - then we completely avoid communicating!
- ·1 päivä sittenHave the Americans written about this lawsuit? If so, have they highlighted Novo's arguments. It is important if one is to be able to use this in marketing.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 5.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 6.5. | ||
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 5.11.2025 |
2026 Q1 -tulosraportti
81 päivää sitten
‧1 t 2 min
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 5.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 6.5. | ||
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 5.11.2025 |
7,95 DKK/osake
Viimeisin osinko
3,65%Tuotto/v
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·21 min sitten · MuokattuHow can many influencer types post so much on social media (before and after pictures) about the use of Lilly's Retatrutide, which is obviously meant to increase awareness of the product before it is FDA approved? It seems they are instructed to call it ""Reta"" - probably because the product is not approved yet! But in the week where we have heard something about Lilly's advertising design, I can't help but wonder if this is okay?? Lilly is not directly the sender of it, but must have some form of responsibility if the people are participating as tests in a phase study. Where else would they get the product from. (Cannot document that it is a Lilly product) https://www.reddit.com/r/BodyHackGuide/s/QFdcpzsFY4
- ·2 t sitten · MuokattuThe Novo share has risen approximately 1.5 percent under Mike Doustar. The CEO stated about his own role when he took office approximately 1 year ago, among other things: "I believe I have ended up in this position because I execute and outperform my competitors." He likewise said that when people ask about the difference between him and former CEO Lars Fruergaard, they answer: "Mike Doustdar is really fast, commercially oriented, Mike is competitive., Mike is confident." In other words, the confident CEO set a clear and more aggressive course for the pharmaceutical giant when he took over the company. It will be interesting to see if he can follow up on the things he has promised. Regarding the lawsuit against Eli Lilly, it is an expression of, and it is commendable, that Novo Nordisk now speaks up if something is wrong. I believe we will see Novo Nordisk more offensive in the protection of its intellectual property rights and at the same time step up the marketing effort in all markets, but especially in the USA.
- ·6 t sittenDear all I would like to suggest that we try to keep posts and discussions within a framework of “what is relevant for most”. Arguments for and against etc. perspectives and questions. With wishes for a likewise proper and factual tone By the way. Whether there are many trolls in here or if some know each other from other forums, I cannot discern, but it succeeds in muddying the forum. Unfortunately, it can have the effect that fewer people feel encouraged to contribute to the conversation, and personally, I completely stop orienting myself due to the noise that the thread is characterized by. In that way, the forum loses its function. From here, with great understanding that one is tempted to “retaliate” to the critical counter-posts that come, I hope that we can restore order in the forum and perhaps sometimes sit on our hands when the factual content has disappeared from the conversation 🙌🏻 Happy Sunday from here ☕️Completely agree! I believe that many serious debaters have been scared away. It would be wonderful if we didn't have to hear about buys, sells and what one has eaten and drunk.
- ·1 päivä sitten · MuokattuLooking forward to Q2-Q3-Q4 etc. Novo has, in my opinion, fallen too far in price. After some years 2022-2024 with enormous growth and reward of the stock price, growth has now been around 0, which has occurred after the years of enormous growth. The price has subsequently been punished more than reasonably and incorrectly signals a company in crisis (P/E). If growth, on the other hand, had come more gradually, we would probably have had a higher stock price on a smaller earnings report. Novo is priced as if the obesity market has never been there and will not come in the future - something that could not be further from reality. 💊💊That's fine Progression - I decline your inquiries going forward. As long as I comply with the guidelines on Nordnet, I am not accountable for your interpretations. And if I don't comply with the guidelines, you simply use the report function that you know so well - then we completely avoid communicating!
- ·1 päivä sittenHave the Americans written about this lawsuit? If so, have they highlighted Novo's arguments. It is important if one is to be able to use this in marketing.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt